Reducing suffering through chemistry
PRODELIC TECHNOLOGIES
Psychedelic Drug Delivery Technologies and ProDrug Designs
We are a pre-clinical biotech company dedicated to revolutionizing psychedelic therapies through advanced drug delivery technologies and novel prodrug designs. By optimizing PharmacoKinetics (PK), we address existing metabolic limitations to minimize off-target actions and broaden patient access to life-changing therapies. Our engineering focus ensures a controlled patient experience and safer, more predictable, therapeutic windows for complex indications. We invite investors and strategic partners to join us in establishing a new scientific standard for precision psychedelic medicine.
MENTAL HEALTH
Treatment-Resistant-Depression
Engineering novel prodrug architectures to enhance metabolic stability and safety profiles for major depression.
TRAUMA CARE
Post-Traumatic Stress Disorder
Optimizing therapeutic windows through precision formulation to ensure consistent pharmacokinetics in trauma recovery.
ANXIETY
Generalized Anxiety Disorder
Developing advanced tryptamine delivery systems to regulate plasma concentrations and achieve a controlled patient experience.
NEUROLOGY
Neurodegenerative Diseases
Utilizing medicinal chemistry and targeted delivery to modulate neuroplasticity and preserve cognitive function at the site.
Clinical Pipeline Focus
Strategic Partnership &
Collaboration Gateway
ProDelic Technologies actively collaborates with leading researchers, clinical sites, and biopharma innovators to drive the evolution of psychedelic drug delivery. Together, we conduct rigorous pre-clinical studies and engage in formulation optimization to refine therapeutic outcomes for patients. Our focus remains on building robust translational pathways that accelerate the movement of breakthroughs from the lab to meaningful clinical application.
We invite you to contact us for more information and/or scientific collaborations.